Trial-based evaluations generally found CBT-I and pharmacotherapy cost-effective versus inactive controls from healthcare and societal perspectives, with ROI studies often indicating CBT-I is ...
In an era of AI “hype,” I sometimes find that something critical is lost in the conversation. Specifically, there’s a yawning gap between AI research and real-world application. Though many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results